CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune ...

LAS VEGAS, Jan ‌6 (Reuters) - Amazon's cloud unit has partnered ‌with German automotive hardware supplier Aumovio to support the commercial rollout of self-driving vehicles, starting with Aurora's ...

AI-powered platform to predict patient safety and efficacy profiles, unlocking precision-driven oncology development BostonGene, the developer of the leading AI foundation model for tumor and immune ...

AI is a strategic enabler throughout the entire development and test process. dSPACE has been exploring how the latest developments in generative and agentic AI technologies can support ...

Northrop Grumman test-fired a solid rocket motor called SMASH!22 Dec. 4 as part of its SMART Demo development program. Credit: Northrop Grumman WASHINGTON — Northrop Grumman tested a solid rocket ...

Taiwan's dedicated chip backend house Lingsen Precision Industries is stepping up capacity expansion and price adjustments as AI-fueled demand for memory chip testing accelerates. President Tse-sung ...

As someone who has spent much of my career working to strengthen New Hampshire’s economic foundation, I’ve long believed that the best development work happens not in boardrooms, but in communities — ...

Amazon Web Services Inc. today introduced a new feature for Kiro, the company’s artificial intelligence-powered agentic coding environment for software developers, adding new “powers” that bring ...

Nest’s design is philosophically inspired by Angular. At its heart is a dependency injection (DI) engine that wires together all the components using a common mechanism. If you are familiar with ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...